Leishmaniasis
ICD-10 B55 is a billable code used to indicate a diagnosis of leishmaniasis.
Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania, transmitted through the bite of infected female phlebotomine sandflies. The disease manifests in various forms, primarily cutaneous leishmaniasis, which causes skin lesions, and visceral leishmaniasis, which affects internal organs such as the liver and spleen. The clinical presentation can vary significantly based on the species of Leishmania involved and the host's immune response. Cutaneous leishmaniasis typically presents with one or more ulcers on the skin, while visceral leishmaniasis may present with fever, weight loss, anemia, and splenomegaly. Diagnosis is primarily through clinical evaluation and laboratory tests, including serological tests and PCR. Treatment options vary depending on the form of the disease and may include antimonial compounds, amphotericin B, or miltefosine. Early diagnosis and treatment are crucial to prevent complications, especially in cases of visceral leishmaniasis, which can be fatal if left untreated.
Detailed clinical history, laboratory results, and treatment plans.
Diagnosis and management of cutaneous and visceral leishmaniasis.
Ensure accurate documentation of travel history and exposure to endemic areas.
Photographic evidence of skin lesions and treatment response.
Management of cutaneous leishmaniasis with topical or systemic therapies.
Document the size, location, and number of lesions for accurate coding.
Used for laboratory confirmation of leishmaniasis.
Document the type of specimen and results.
Infectious disease specialists should ensure accurate lab results are included.
Common symptoms include skin ulcers for cutaneous leishmaniasis and fever, weight loss, and splenomegaly for visceral leishmaniasis.
Diagnosis is typically made through clinical evaluation, serological tests, and PCR to confirm the presence of Leishmania parasites.
